Company Profile for Nanotherapeutics, Inc.

--()--Nanotherapeutics, Inc. (www.nanotherapeutics.com) is a privately held biopharmaceutical company with a major focus on developing a diversified proprietary pipeline of products having both biodefense and medical applications. Products under development include biodefense medical countermeasures, CNS, wound healing, addiction and pain, oncology, anti-infectives, vaccines and orthopedics. The Company has one FDA cleared injectable biologic, NanoFUSE® DBM, used by orthopedic surgeons as bone graft filler. Nanotherapeutics has in-house cGMP manufacturing, formulation, and expertise in pre-clinical and clinical product development as well as clinical trial management to support its products. Established in 1999, the Company employs several proprietary platform technologies to manipulate and enhance the properties of drug candidates.

     

Company:

Nanotherapeutics, Inc.

 

Headquarters Address:

13859 Progress Blvd
Suite 300
Alachua, FL 32615
 

Main Telephone:

386-462-9663
 

Website:

www.nanotherapeutics.com

 

Type of Organization:

Private
 

Industry:

Biotechnology
 

Key Executives:

President & Chief Executive Officer: James D. Talton, Ph.D

CFO: James M. Matthew

 

Investor Relations

Contact:

Gary Ascani

Phone:

386-462-9663

Email:

gascani@nanotherapeutics.com

 

Sharing

Contacts